Synthesis and antimicrobial activity of new pyrimidine derivatives incorporating 1H-tetrazol-5-ylthio moiety

Journal of Heterocyclic Chemistry

Volumn 50, Issue 6, 2013, Pages 1446-1450

  Disli A ^a   Mercan, S ^a   Yavuz, S ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

1H TETRAZOL 5 YLTHIO DERIVATIVE; 2 AMINO 4,6 DIMETHOXY 5 THIOCYANATOPYRIMIDINE; 2 AMINO 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 (1 BENZYL 1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 (1 ETHYL 1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 (1 HEXYL 1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 (1 PROPYL 1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 (1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 [1 (CYCLOHEXYLMETHYL) 1H TETRAZOL 5 YLTHIO] 4,6 DIMETHOXYPYRIMIDINE; 2 AMINO 5 [1 (CYCLOPROPYL,ETHYL) 1H TETRAZOL 5 YLTHIO] 4,6 DIMETHOXYPYRIMIDINE; 2 CHLORO 4,6 DIMETHOXY 5 THIOCYANATOPYRIMIDINE; 2 CHLORO 5 (1H TETRAZOL 5 YLTHIO) 4,6 DIMETHOXYPYRIMIDINE; 2 CHLORO 5 [1 (CYCLOPROPYLMETHYL) 1H TETRAZOL 5 YLTHIO] 4,6 DIMETHOXYPYRIMIDINE; AMPICILLIN; ANTIINFECTIVE AGENT; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PYRIMIDINE DERIVATIVE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CHEMICAL REACTION; CONTROLLED STUDY; DIAZOTIZATION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 84888640024     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.1585     Document Type: Article

References (27)

1. Lobo, G.; Charris, J.; Valderrama, M.; Romero, J.; Castelli, C.; Taddei, A., Molbank 2010, 1, M653.
2. Prabakaran, P.; Robert, J. J.; Muthiah, P. T., Acta Crystallogr 2001, C.57, 459.
3. Gössnitzer, E.; Wagner, G.; Feierl U., Eur J Pharm Sci 2002, 15, 49.
4. Ram, V. J.; Haque, N., Indian J Chem 1995, 34B, 521.
5. Calis, U.; Koksal, M., Arzneimittelforschung 2001, 51, 523.
6. Saladino, R.; Ciambecchini, U.; Maga, G.; Mastromarino, P. P.; Conti, C.; Botta, M., Bioorg Med Chem 2002, 10, 2143.
7. San-Felix, A.; Velazquez, S.; Perez, M. J.; Balzarini, J.; De Clercq, E.; Canarasa, M. J., J Med Chem 1994, 37, 453.
8. Vanden, J.; Audiart, N.; Canonne, V.; Michel, S.; Van Haverbeke, Y.; Kappe, C.,; Heterocycles 1997, 45, 1967.
9. Varma, R. S., Green Chem 1999, 1, 43.
10. Kappe, C. O.; Fabian, W. M. F.; Semones, M. A., Tetrahedron 1997, 53, 2803.
11. Al-Omar, M. A.; Amr, A. E. E., Molecules 2010, 15, 4711.
12. Patel, D. H.; Chikhalia, K. H.; Shah, N. K.; Patel, D. P.; Kaswala, P. B.; Buha, V. M., Pharm Chem J 2010, 44 (2), 94.
13. Jin, H.; Randazzo, J.; Zhang, P.; Kador P. F., J Med Chem 2010, 53, 1117.
14. Patel, R. B.; Desai, K. R.; Chikhalia, K. H., J Ind Chem 2006, 45B, 773.
15. Madding, D. G.; Thompson, D. M., J Heterocycl Chem 1987, 24, 581.
16. Singh, H., Chala, A. S., Kapoor, V. K.; Paul, D.; Malhotra, R. K., Prog Med Chem 1980, 17, 151.
17. Burger, A., Prog Drug Res 1991, 37, 287.
18. Shekarchi, M.; Marvasti, M. B.; Sharifzadeh, M.; Shafiee, A., Iran J Pharm Res 2005, 1, 33.
19. Kumar, P.; Knaus, E. E., Drug Des Discov 1994, 11, 15.
20. Sonar, S. S.; Sadaphal, S. A.; Pokalwar, R. U.; Shingate, B. B.; Shingare, M. S., J Heterocyclic Chem 2010, 47, 441.
21. Demko, Z. P.; Sharpless, K. B., Angew Chem 2002, 41, 2113.
22. Özkan, H.; Yavuz, S.; Dişli, A.; Yildirir, Y.; Türker, L., Heteroatom Chem 2007, 18 (3), 255.
23. Yildirir, Y.; Us, M. F.; Çolak, N.; Özkan, H.; Yavuz, S.; Disli, A.; Öztürk, S.; Türker, L., Med Chem Res 2009, 18, 1891.
24. Dişli, A.; Salman, M., Russ J Org Chem 2009, 45, 151.
25. Yavuz, S.; Aydin, Ö.; Çete, S.; Dişli, A.; Yildirir, Y., Med Chem Res 2010, 19, 120.
26. Cruickshank, R.; Duguid, J. P.; Marion, B. P.; Swain, R. H. A., Medicinal Microbiology, 12th ed., Vol. II, Churchil Livingstone: London, 1975; pp. 196-202.
27. Collins, A. H., Microbiological Methods, 2nd ed. Butterworth, London, 1976.